Uncategorized
FDA approves Actemra for giant cell arteritis
The FDA has approved Actemra for the treatment of adults with giant cell arteritis. “Rheumatologists will finally have available an option for their patients that is going to allow them to discontinue steroids as rapidly as possible,” Christine Birchwood, PhD, senior medical science director from Genentech, told Healio Rheumatology. “It is the first new therapy these patients will have had in more than 50 years.”